Beam Therapeutics Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -762.3% | – | – | |
| – | +5,809.1% | +438.9% | +35.2% | +57.4% | +89.9% | +41.5% | +9.6% | +1.7% | |
| – | +3,436.4% | +0.4% | +118.8% | +183.3% | +93.5% | +17.0% | +22.3% | -21.9% | |
| – | – | -83.9% | +556.3% | +109.2% | -90.9% | – | – | – | |
| – | +1,261.5% | -206.3% | – | +1,980.7% | +126.2% | -146.3% | – | – | |
| – | +3,693.1% | -4.6% | +30.7% | +186.2% | +4.6% | -31.1% | -73.5% | +67.1% | |
| – | +3,779.8% | +396.6% | +50.2% | +193.8% | +56.8% | – | +157.5% | -165.6% | |
| – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | – | +0.0% | -70.3% | -224.7% | +8.0% | -1.5% | -78.5% | -100.0% | |
| – | +3,506.1% | -77.0% | +680.8% | +134.6% | -85.2% | +147.7% | -97.2% | +6,079.5% | |
| – | +7,461.1% | -166.7% | – | +212.9% | -182.7% | – | -177.6% | – | |
| – | – | – | – | – | – | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.